FTV240920C65000
- 7.00
- 0.000.00%
Fortive Newsroom
Fortive (FTV) Gets a Hold From Wells Fargo
Least Shorted S&P 500 Stocks in July
Wells Fargo Keeps Their Hold Rating on Fortive (FTV)
More Than Half Of Fortune 500 Companies Flag AI As A Major Risk, Marking 473.5% Surge In Warnings Amid Growing Concerns
Short Interest on S&P 500 Industrial Dips After Rising for Five Months
Fortive Corporation's (NYSE:FTV) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Fortive Stock Outlook: Is Wall Street Bullish or Bearish?
After a volatile week, Goldman Sachs reevaluates AI stocks: high-quality companies are very attractive.
Goldman Sachs pointed out that even though the market is tired of AI concept stocks, high-quality AI stocks are still attractive as these companies have strong technical foundations, market positions, or growth potential in the AI field. In addition, Nvidia's financial report, which will be released at the end of this month, may have a major impact on the entire AI market.
Citi Spotlights 33 Stocks in What It Calls Its 'Post Pullback Shopping List'
Express News | Fortive's Advanced Sterilization Products Announces FDA Clearance Of ULTRA GI Cycle In The STERRAD 100NX Sterilizer
Express News | Advanced Sterilization Products Announces FDA Clearance for Revolutionary Sterilization Cycle for Duodenoscopes in Partnership With Pentax Medical
PENTAX Medical Receives FDA Clearance for Duodenoscope With New Sterilization Technology in Collaboration With Advanced Sterilization Products.
Fortive Corporation (NYSE:FTV) Shares Could Be 39% Below Their Intrinsic Value Estimate
Wells Fargo Maintains Fortive(FTV.US) With Hold Rating, Maintains Target Price $75
Wells Fargo Reaffirms Their Hold Rating on Fortive (FTV)
Fortive Corporation (FTV): The Best Scientific Instruments Stock to Buy According to Hedge Funds?
Evercore Maintains Fortive(FTV.US) With Buy Rating, Raises Target Price to $80
New Buy Rating for Fortive (FTV), the Technology Giant
Fortive Downgraded at CFRA on Stock's Valuation
Fortive Price Target Cut to $77.00/Share From $83.00 by RBC Capital